GSK Stock 12 Month Analyst Forecast
Eps Overview
Growth Next 5yrs
9.8%
Last Quarter
$1.27
Past Year
$1.93
Growth Past 5yrs
-11.63%
Next Quarter
$1.25
Estimate Next Year
$0.56
Consensus Rating
Loading...
Consensus Price Target
Highest Price Target
N/A
(
0% Upside
)Mean Price Target
N/A
(
0% Upside
)Lowest Price Target
N/A
(
0% Upside
)Recent Analyst Ratings
Upgrades, Downgrades, New Coverage
Actual EPS vs Estimated EPS
GSK Earnings Per Share (EPS) History
According to financial reports, GSK (NYSE: GSK) reported an actual EPS of $1.27 for the quarter ending on Oct 30, 2024, compared to an estimated $1.16, resulting in a 9.48% surprise. In the prior quarter (Jul 31, 2024), GSK recorded an actual EPS of $1.09 with a 9.00% surprise. See GSK's full earnings history.
Earnings History
EPS Surprise Factor Analysis
GSK has experienced notable EPS surprises, with the latest quarter ending Oct 30, 2024 showing a 9.48% beat. Previously, the quarter ending Jul 31, 2024 recorded a 9.00% beat. An EPS surprise factor indicates how much actual earnings deviate from analyst forecasts.
Frequently Asked Questions
Is GSK stock getting favorable reviews from Wall Street analysts?
Brokerage firms have given GSK stock an average recommendation of
N/A. 0 analysts have given their ratings
to GSK out of which
0 analysts have given strong buy call,
0 analysts have given buy call,
0 analysts rate it hold,
0 analysts advocate strong sell call, and
0 analysts has given sell rating. The average target price of
- gives the stock implied downside
of roughly 0% over the next year or so.
What have analysts suggested for GSK highest price target?
Analysts suggest GSK's stock price would rise to a high of -.
What is the lowest price target analysts expect for GSK over the next year?
Within the next 12 months, analysts predict the GSK stock price could move to -.
What is the average target price for GSK?
GSK stock has an average analyst estimate of -.
At its current price, how far is GSK from its average target price?
GSK shares are currently trading 0% below this price target.
What were GSK’s actual earnings per share for the recent quarter?
Its quarterly earnings per share (EPS) came in at $1.27 versus consensus estimates of $1.16, and above the comparable year-ago quarter’s EPS of $1.26.
What are the current estimates for quarterly and annual earnings per share?
GSK's forecasts by analysts estimating quarterly EPS at $1.25 and $0.56 for the whole year.
What has GSK's growth been in the past five years and what is expected in the next five years?
The analysts have projected 9.8% EPS growth for GSK in the next five years, compared to growth rates of -11.63% in the past five years.